Cargando…
COVID19 inhibitors: A prospective therapeutics
The inhibition of viral targets might provide new therapies for coronavirus disease abbreviated as COVID-19. The rational drug design identified as much of the recent discoveries of potent drugs molecule against any targets. This results in an improvement in bindings for better potency and selectivi...
Autor principal: | Jawaid Akhtar, Md |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297670/ https://www.ncbi.nlm.nih.gov/pubmed/32629280 http://dx.doi.org/10.1016/j.bioorg.2020.104027 |
Ejemplares similares
-
Technology Enhanced Assessment (TEA) in COVID 19 Pandemic
por: Khan, Rehan Ahmed, et al.
Publicado: (2020) -
The bioenergetics of COVID-19 immunopathology and the therapeutic potential of biophysical radiances
por: Surazakov, Arzhan, et al.
Publicado: (2020) -
Prospects of honey in fighting against COVID-19: pharmacological insights and therapeutic promises
por: Hossain, Khandkar Shaharina, et al.
Publicado: (2020) -
How to run a successful Journal
por: Jawaid, Shaukat Ali, et al.
Publicado: (2017) -
Respiratory delivery of favipiravir-tocilizumab combination through mucoadhesive protein-lipidic nanovesicles: prospective therapeutics against COVID-19
por: Thakur, Vikram, et al.
Publicado: (2021)